RBOT vs. NTRB, COCH, MLSS, LFWD, CLGN, INGN, SEPA, EQ, CTSO, and ENZ
Should you be buying Vicarious Surgical stock or one of its competitors? The main competitors of Vicarious Surgical include Nutriband (NTRB), Envoy Medical (COCH), Milestone Scientific (MLSS), ReWalk Robotics (LFWD), CollPlant Biotechnologies (CLGN), Inogen (INGN), SEP Acquisition (SEPA), Equillium (EQ), Cytosorbents (CTSO), and Enzo Biochem (ENZ). These companies are all part of the "medical" sector.
Nutriband (NASDAQ:NTRB) and Vicarious Surgical (NYSE:RBOT) are both small-cap medical companies, but which is the better stock? We will compare the two businesses based on the strength of their profitability, earnings, media sentiment, analyst recommendations, dividends, risk, institutional ownership, valuation and community ranking.
Vicarious Surgical received 5 more outperform votes than Nutriband when rated by MarketBeat users. Likewise, 38.10% of users gave Vicarious Surgical an outperform vote while only 37.50% of users gave Nutriband an outperform vote.
Nutriband has a beta of 0.97, indicating that its stock price is 3% less volatile than the S&P 500. Comparatively, Vicarious Surgical has a beta of 1.16, indicating that its stock price is 16% more volatile than the S&P 500.
Vicarious Surgical has a consensus target price of $0.67, indicating a potential upside of 100.92%. Given Nutriband's higher probable upside, analysts plainly believe Vicarious Surgical is more favorable than Nutriband.
In the previous week, Nutriband had 1 more articles in the media than Vicarious Surgical. MarketBeat recorded 4 mentions for Nutriband and 3 mentions for Vicarious Surgical. Vicarious Surgical's average media sentiment score of 1.03 beat Nutriband's score of -1.01 indicating that Nutriband is being referred to more favorably in the media.
Nutriband has higher revenue and earnings than Vicarious Surgical. Nutriband is trading at a lower price-to-earnings ratio than Vicarious Surgical, indicating that it is currently the more affordable of the two stocks.
19.7% of Nutriband shares are owned by institutional investors. Comparatively, 47.3% of Vicarious Surgical shares are owned by institutional investors. 43.2% of Nutriband shares are owned by company insiders. Comparatively, 11.7% of Vicarious Surgical shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.
Vicarious Surgical has a net margin of 0.00% compared to Vicarious Surgical's net margin of -262.94%. Vicarious Surgical's return on equity of -73.71% beat Nutriband's return on equity.
Summary
Vicarious Surgical beats Nutriband on 8 of the 15 factors compared between the two stocks.
Get Vicarious Surgical News Delivered to You Automatically
Sign up to receive the latest news and ratings for RBOT and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding RBOT and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Vicarious Surgical Competitors List
Related Companies and Tools
